Surgical Management and Prognostic Analysis of Intracranial Arteriovenous Malformation Within the Hybrid Operating Room: a Prospective Single-Arm Study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031523

Enrollment

Unknown

Registered

2020-04-03

Start date

2016-10-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriovenous malformation

Interventions

single arm:hybrid operation

Eligibility

Sex/Gender

All

Age

12 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years; 2. All patients were diagnosed with high-grade intracranial arteriovenous malformations by MRA/CTA/DSA before evaluation (SM M grade >= 3); 3. Patients can take care of themselves with a KPS scale (mRS)>60 ; 4. Patients' families will sign informed consent and cooperate with clinical treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with other systemic refractory disease, such as acute heart infarction, renal dysfunction and malignant tumor, etc.; 2. Pregnant or lactating women, or a positive pregnancy test on admission; 3. Patients with other systemic diseases, such autoimmune disease or blood disorder; 4. Patients participate in other similar studies.

Design outcomes

Primary

Measure	Time frame
GOS;mRS;AVM residual;	—

Countries

China

Contacts

Public ContactWei Zhu

Department of Neurosurgery, Huashan Hospital, Fudan University

drzhuwei@fudan.edu.cn+86 18621120936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026